These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30297597)

  • 1. Predictive value of baseline C-reactive protein for periprocedural myocardial infraction of higher risk stratifications: A retrospective cohort clinical study.
    Yao M; Zhao L; Wu L; Zhang W; Luan Y; Song J; Fu G; Zhu J
    Anatol J Cardiol; 2018 Dec; 20(6):310-317. PubMed ID: 30297597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
    Patti G; Mangiacapra F; Ricottini E; Cannatà A; Cavallari I; Vizzi V; D'Ambrosio A; Dicuonzo G; Di Sciascio G
    Am J Cardiol; 2013 Jun; 111(12):1739-44. PubMed ID: 23538022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
    Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
    Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.
    Kang MG; Kang Y; Jang HG; Kim K; Koh JS; Park JR; Hwang SJ; Hwang JY; Bae JS; Ahn JH; Jang JY; Park Y; Jeong YH; Kwak CH; Park HW
    Coron Artery Dis; 2018 Nov; 29(7):589-596. PubMed ID: 29965838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural myocardial infarction during percutaneous coronary intervention in an academic tertiary centre in Johannesburg.
    Tsabedze N; McCutcheon K; Mkhwanazi L; Garda R; Vachiat A; Ramjee R; Moosa J; Maluleke T; Mukeshimana G; Karolia S; Mpanya D; Manga P
    Int J Cardiol; 2017 Mar; 230():175-180. PubMed ID: 28062147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry.
    Arai T; Yuasa S; Miyata H; Kawamura A; Maekawa Y; Ishikawa S; Noma S; Inoue S; Sato Y; Kohsaka S; Fukuda K
    Heart Vessels; 2013 Nov; 28(6):714-9. PubMed ID: 23274577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Stetler J; Karatasakis A; Christakopoulos GE; Tarar MN; Amsavelu S; Patel K; Rangan BV; Roesle M; Resendes E; Grodin J; Abdullah S; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):1-6. PubMed ID: 27014962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Zhang D; Li Y; Yin D; He Y; Chen C; Song C; Yan R; Zhu C; Xu B; Dou K
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):534-540. PubMed ID: 28191726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty.
    Ricottini E; Mangiacapra F; Nusca A; Melfi R; Cavallari I; Miglionico M; Gallo P; Pozzilli P; Di Sciascio G
    Am J Cardiol; 2018 May; 121(9):1027-1031. PubMed ID: 29571721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
    Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Kirtane AJ; Zhang RY
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():616-23. PubMed ID: 26864270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.
    Koskinas KC; Ndrepepa G; Räber L; Karagiannis A; Kufner S; Zanchin T; Hieber J; Hunziker L; Mayer K; Byrne RA; Heg D; Windecker S; Kastrati A
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e006752. PubMed ID: 30545257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
    Ishibashi Y; Muramatsu T; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Cho YK; Garcia-Garcia HM; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; McClean D; de Sousa Almeida M; Wasungu L; Miquel-Hebert K; Dudek D; Chevalier B; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; De Luca G;
    Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of postpercutaneous coronary intervention myocardial infarction: insights from intravascular imaging, coronary flow, and biomarker evaluation.
    Hoole SP; Hernández-Sánchez J; Brown AJ; Giblett JP; Bennett MR; West NEJ
    Coron Artery Dis; 2018 May; 29(3):246-253. PubMed ID: 29112510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.
    Xu LX; Chen KY; Liu T; Zheng XT; Jiao ZQ; Xu Y; Li G
    Cardiovasc Ther; 2016 Aug; 34(4):225-33. PubMed ID: 27133311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and myocardial infarction during percutaneous coronary intervention.
    Saleh N; Svane B; Velander M; Nilsson T; Hansson LO; Tornvall P
    J Intern Med; 2004 Jan; 255(1):33-9. PubMed ID: 14687236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.